Provided by Tiger Fintech (Singapore) Pte. Ltd.

Veru Inc.

0.5249
+0.00420.81%
Volume:785.56K
Turnover:408.13K
Market Cap:76.84M
PE:-2.00
High:0.5300
Open:0.5200
Low:0.5077
Close:0.5207
Loading ...

FOCUS-Next generation weight loss drugs aim to save muscle

Reuters
·
19 Feb

Oppenheimer Adjusts Price Target on Veru to $4 From $5, Keeps Outperform Rating

MT Newswires Live
·
14 Feb

Veru Inc (VERU) Q1 2025 Earnings Call Highlights: Strategic Shifts and Clinical Progress Amid ...

GuruFocus.com
·
14 Feb

Veru Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
13 Feb

Veru Q1 Adj EPS $(0.07) Beats $(0.08) Estimate

Benzinga
·
13 Feb

Veru Inc - Q1 Net Loss From Cont Ops $0.01 per Share

THOMSON REUTERS
·
13 Feb

Veru Q1 2025 GAAP EPS $(0.06) Beats $(0.07) Estimate, Cash, Cash Equivalents, And Restricted Cash Were $26.6M

Benzinga
·
13 Feb

Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress

GlobeNewswire
·
13 Feb

Veru Inc expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
11 Feb

Veru to Report Fiscal 2025 First Quarter Financial Results on February 13, 2025

GlobeNewswire
·
06 Feb

Veru Inc expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
04 Feb

Largest borrow rate increases among liquid names

TIPRANKS
·
30 Jan

Veru Inc.’s Promising Phase IIb Results Suggest Investment Opportunity with Enobosarm’s Weight Management Potential

TIPRANKS
·
28 Jan

S&P 500 Falls Over 100 Points; Dada Nexus Shares Spike Higher

Benzinga
·
28 Jan

Nasdaq Dips 3%; Chicago Fed National Activity Index Rises In December

Benzinga
·
27 Jan

Veru's Enobosarm Meets Primary Endpoint of Preserving Lean Body Mass in Phase 2b Study

MT Newswires Live
·
27 Jan